home.aspx

 
. home.aspx home.aspx

ARCHIVED NEWS


    ETHICS OF ANCIENT DNA

    Oct 14, 2019

    In recent years, the study of ancient DNA, also known as a DNA, has rapidly advanced, providing important insights into a range of biological, historical, and social questions. The study of a DNA has helped illuminate the evolution of diseases, ancient migration patterns, the impacts of European col...


    READ MORE

    /news-article.aspx?ID=35823582

    IT'S TIME TO KEEP CHECK ON THE MICROBIOME

    Oct 14, 2019

    The human body provides a home to microbes of different varieties, including bacteria, archaea, fungi, viruses, protists and microscopic animals. The collective sum of these organisms is known as the human microbiome, Over recent years, the human microbiome has garnered increased research attention,...


    READ MORE

    /news-article.aspx?ID=35833583

    POWERFUL TECHNIQUE TRACKS DOWN GENETIC DISEASE

    Oct 14, 2019

    A team led by a scientist at Scripps Research has invented a new genomics technique for tracking down the causes of rare genetic diseases. The technique, which the researchers report in Science, makes use of the fact that people inherit two copies or "alleles" of virtually every gene, one ...


    READ MORE

    /news-article.aspx?ID=35843584

    BIOINFORMATICS HUB AT UCHICAGO ENABLES INFECTIOUS DISEASE RESEARCH

    Oct 11, 2019

    The University of Chicago has recently announced that it has setup a new bioinformatics research centre funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services. The most valuable weapon against the next deadly diseas...


    READ MORE

    /news-article.aspx?ID=35793579

    RNA THERAPY IMPROVES VISION IN UNTREATABLE GENETIC BLINDNESS

    Oct 11, 2019

    A phase I/II trial run by the Dutch company ProQR has found that its RNA therapy could significantly improve the vision of people with Leber’s congenital amaurosis, a rare genetic disease for which there is no treatment. The RNA drug, called sepofarsen, is designed to treat people with a speci...


    READ MORE

    /news-article.aspx?ID=35803580

    DECODING THE GENETIC MECHANISMS OF AGING

    Oct 11, 2019

    The discovery in the 1990s that a mutation in a single gene of an experimental worm could double its lifespan set off a stampede of research on the molecular biology of aging and triggered hopes that drug therapies or other interventions could be developed to extend healthy human lifespan. But as is...

    MDI BIOLOGICAL LABORATORY
    READ MORE

    /news-article.aspx?ID=35813581

    DRUG ABSTINENCE CHANGES GENE EXPRESSION, MAKING RELAPSE MORE LIKELY

    Oct 10, 2019

    A new preclinical study by University at Buffalo researchers reveals the genetic basis of relapse, one of the most detrimental but poorly understood behaviors related to addiction. Craig Werner, PhD, is first author on a paper published in Science Advances that demonstrates how prolonged abstinence ...


    READ MORE

    /news-article.aspx?ID=35763576

    DEVELOPING POTENT AFFIMER-DRUG CONJUGATES

    Oct 10, 2019

    Avacta, a biotechnology company developing novel cancer immunotherapies based on its proprietary Affimer® platform, has announced that it has entered a collaboration and option agreement with ADC Therapeutics, a clinical-stage oncology-focused biotechnology company focusing on the development of...


    READ MORE

    /news-article.aspx?ID=35773577

TRENDING NEWS


    REVERSE-ENGINEERED SIMULATIONS COULD POWER NEW SCIENTIFIC DISCOVERIES

    Nov 13, 2019

    Scientists have built simulations to help explain behavior in the real world, including modeling for disease transmission and prevention, autonomous vehicles, climate science, and in the search for the fundamental secrets of the universe. But how to interpret vast volumes of experimental data in ter...


    READ MORE

    /news-article.aspx?ID=36393639

    DATA ANALYTICS TO BECOME “CENTRAL PILLAR” OF BIOMANUFACTURING

    Nov 13, 2019

    The pharmaceutical industry could get more efficient by more efficiently using data produced by bioprocessing. That’s according to Michael Sokolov, PhD, co-founder and COO of DataHow. In an exclusive interview, he explained that the pharma industry needs to, “to use fewer resources while...


    READ MORE

    /news-article.aspx?ID=36403640

    GENE THERAPY PRODUCTION AND QUALITY CONTROL

    Nov 13, 2019

    Gene therapy is an emerging field and industry is yet to work out how best to manufacture these life-saving products says expert. Interest in gene therapy is growing, says Andrew Powaleny, public affairs director at the Pharmaceutical Research and Manufacturers of America (PhRMA). “As of Decem...


    READ MORE

    /news-article.aspx?ID=36413641

    WHAT DO WE KNOW ABOUT THE GUT MICROBIOTA IN PARKINSON’S DISEASE?

    Nov 12, 2019

    Since the discovery that the gut microbiome may play a role in the development of Parkinson's disease (PD), this fresh scientific approach has produced varying results. In this review published in the Journal of Parkinson's Disease scientists compare results of current research and provide r...


    READ MORE

    /news-article.aspx?ID=36363636

    GLYGEN HELPS RESEARCHERS ANSWER GLYCAN-RELATED QUESTIONS USING BIG DATA

    Nov 12, 2019

    Of the four building blocks of life – proteins, lipids, nucleic acids and glycans (carbohydrates) – the latter have received the least attention from researchers. This may be about to change as a new project, GlyGen, launches to help researchers answer glycan-related questions using big ...


    READ MORE

    /news-article.aspx?ID=36373637

    IS DNA ONE IN A MILLION?

    Nov 12, 2019

    Biology encodes information in DNA and RNA, which are complex molecules finely tuned to their functions. But are they the only way to store hereditary molecular information? Some scientists believe life as we know it could not have existed before there were nucleic acids, thus understanding how they...


    READ MORE

    /news-article.aspx?ID=36383638

    CRISPR GENE EDITING ABILITY IMPROVED BY SPECIFIC MODIFICATIONS OF TRACRRNA

    Nov 11, 2019

    Scientists at the City of Hope believe they may have found a way to sharpen the fastest, cheapest, and most accurate gene editing technique, CRISPR-Cas9, so that it can more successfully cut out undesirable genetic information. This improved cutting ability could one day fast-track potential therapi...


    READ MORE

    /news-article.aspx?ID=36333633

    BETTER BIOSENSOR TECHNOLOGY CREATED FOR STEM CELLS

    Nov 11, 2019

    A Rutgers-led team has created better biosensor technology that may help lead to safe stem cell therapies for treating Alzheimer’s and Parkinson’s diseases and other neurological disorders.
    The technology, which features a unique graphene and gold-based platform and high-tech imag...


    READ MORE

    /news-article.aspx?ID=36343634

    CELGENE, ACCELERON WIN FDA OK FOR DRUG TO TREAT ANEMIA IN ADULTS WITH BETA THALASSEMIA

    Nov 11, 2019

    Celgene and Acceleron Pharma have won a first-in-class FDA approval for Reblozyl® (luspatercept-aamt), an erythroid maturation agent that has won the agency’s first authorization to treat anemia in adults with beta thalassemia who require regular red blood cell (RBC) transfusions. Reblozyl...


    READ MORE

    /news-article.aspx?ID=36353635

    THE SELF-CANNIBALIZING MITOCHONDRIA AT THE ORIGIN OF ALS

    Nov 08, 2019

    Northwestern Medicine scientists have discovered a new phenomenon in the brain that could explain the development of early stages of neurodegeneration that is seen in diseases such as ALS, which affects voluntary muscle movement such as walking and talking. The discovery was so novel, the scientists...


    READ MORE

    /news-article.aspx?ID=36303630

    MACHINE LEARNING HARNESSED TO BUILD MAP OF THE CONNECTOME

    Nov 08, 2019

    The brain is considered to be one of the most complex systems in existence. And while significant headway has been made to understand it, we tend to generate more questions than answers. But now a research team led by Kyoto University has developed a machine learning model that allows scientists to ...


    READ MORE

    /news-article.aspx?ID=36313631

    STUDY VACCINE PROTECTS MONKEYS AGAINST FOUR TYPES OF HEMORRHAGIC FEVER VIRUSES

    Nov 08, 2019

    Scientists funded by the National Institutes of Health have developed an investigational vaccine that protected cynomolgus macaques against four types of hemorrhagic fever viruses endemic to overlapping regions in Africa. The University of Texas Medical Branch in Galveston and Profectus BioSciences ...


    READ MORE

    /news-article.aspx?ID=36323632

SPOTLIGHT

Microorganisms like bacteria, fungi, archaea, algae, protozoa, and viruses, known as microbes, play a critical role in many different phenomena. They are involved in climate change, nutrient cycling, biodegradation and diseases.

RESOURCES

Events